Dr. Barzilai is a chaired Professor of Medicine and Genetics and Director of the biggest Center in the world to study the Biology of Aging. He is the recipient of an NIH Merit Award aiming to extend the healthy life span in rodents by biological interventions. He also studies families of centenarians that have provided genetic/biological insights on the protection against aging. Several drugs are developed based, in part, on these paradigm-changing studies. He is a recipient of numerous prestigious awards, including the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity award. He is leading the TAME (Targeting/Taming Aging with Metformin) multi central study to prove that concept that multi morbidities of aging can be delayed in humans and change the FDA indications to allow for next generation interventions. He has been featured in major papers, TV program and documentaries and has been Consulting or presented the promise for targeting aging at The Singapore Prime Minister Office, several International Banks, Pepsico, Milkin Institute, The Economist and Wired Magazine
Douglas N. Ishii was born in a concentration camp in California at the onset of W.W.II. He received a B.A. in biochemistry at Univ. Calif. Berkeley, a Ph.D. in pharmacology at Stanford Univ. School of Medicine, and conducted postdoctoral studies in neurobiology at the same institution. He was Assoc. Prof. Pharmacology at Columbia Univ. N.Y.C., and is presently Prof. Biomedical Sciences at Colorado State Univ. He has served on many scientific review panels for N.I.H., N.S.F., and Juvenile Diabetes Found. Internatl. Awards include 20 issued patents for the treatment of neurodegenerative diseases. Dr. Ishii is a founder of Aurogen Inc., a biotechnology company dedicated to developing new treatments for Alzheimer's disease.
The aim is to evaluate foot Charcot's neuroarthropathy in diabetics in at tertiary hospitals in Jeddah (KSA).
The study is a retrospective one, completed at the Surgical Department of King Abdulaziz University Hospital from 2005 – 2015 inclusive ( 64 patients in 11 years, mean age 61.75 years with male/female ratio 4:1.).The study items were: patient demography, exact presenting symptoms duration, type of diabetes present, presence of history of trauma, deformity, ulcer, peripheral vascular disease, obesity, hypertension, and history of previous surgery. Decumented also was the exact site of involvement (mid, hind or fore-foot) and any given treatment . Results : Pain was reported in 25%, numbness 12.5%, deformity 23.4%, discharge 73.4%, and difficulty in walking in 12.5%.. Eleven percent of patients reported history of trauma. Majority of patients (68.8 %) had their diabetes of the no-ninsulin depentdent type lasting > 10 years. It was fully controlled in 21.9%. Other findindgs were: Nephropathy 46.3% , neuropathy 59.4%, retinopathy 40.6%, cardiomyopathy 48.4% and vasculopathy in 56.3% of cases. Charcot arthropathy involved forefoot in 65.5%, midfoot 4.7% and hindfoot/ankle in 21.9% of cases. Insult present as proven by x-ray as: subluxation 40.6%, dislocation 54.7%, disorganization 42.2%, bone resorption 23.4%, osteomyelitis 14.1%, fractures 50%, and in 39.1%. Three quqrters of patients required some sort of amputation , while debridement was sufficient for the rest. Conclusions Charcot joint in the feet of diabetics pose great challenge in management. Emphasis should be given for early detection and prompt treatment, to be tailored according to the lesion
CaweNovukela is currently studying towrads Ph.D at Walter Sisulu University and is the Dean of the Faculty of Business Sciences. Dr M J Ntsaba is the Head of Department of Nursing at Walter Sisulu and has several peer reviewed publications and has supervised more than 25 Masters and Ph.D students. Prof S K Mfusi is the Head of Department of Psychology. He has several publications in reputable journals and has supervised more than 20 Masters and PhD students.
Fan Hongmin has completed his PhD from Peking Union Medical College, CHINA and postdoctoral studies and senior visiting scholar from West virginia University, USA. She is the deputy director of preventive medicine,School of publich health, Norh China of Science and Technology, CHINA. She has published more than 70 papers in reputed journals and has been serving as many editorial board member of repute.
Tianjiu Research and Development Centre for Exercise Nutrition and Foods, China
Ning Chen has completed his PhD from Georgia State University in USA. He is a Chutian Scholar Distiguished Professor in Biochemistry and Molecular Exercise Physiology in College of Health at Wuhan Sports University in China. He is also the director of Tianjiu Research and Development Centre for Exercise Nutrition and Foods and the director of Hubei Key Laboratory of Sport Training and Monitoring at Wuhan Sports University. He has published more than 50 papers in reputed journals and has been serving as the editorial board member of serveral international journals
Adil O. Bahathiq had initial experience of the research tools with Professors Ian Cooke and William Ledger at University of Sheffield, U.K.He found newdata the Fallopian tube and epididymis for his Ph.D. Then he conducted a new line of research that helped and improved the healthof the community. He hasdeveloped this area after years of experience in research, evaluation, teaching and administration both in hospital and educational institutions. This research areawaschosen because of the lack of data relating to obesity and the metabolic syndrome in the children and adults of the Makkah community. The findings of this research have beenbeneficial to the authorities in the fields of education and health in Saudi Arabia.
James David Adams
University of Southern California School of Pharmacy, USA
DR JOSEPH KUNNIRICKAL JOSEPH has completed his under graduation medical degree from Tribhuvan university Nepal.He did his post graduation in medicine from Rajiv Gandhi University of Health Sciences,2014.He also undergone a certification course in diabetes by the Public Health Foundation of India.Dr Joseph is a pioneer in the use of the latest degludac,GLP1 agonists and SGLT 2 Inhibitors at the city of kochi and has successfully treated many diabetes patients with uncontrolled sugars on conventional therapies.He regularly contributes articles on diabetes to Indian magazines and newspapers.He is a 2018 finalist of the BMJ awards south asia edition under healthcare innovation of the year category for the same topic.
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, Suchkov maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology. In 2001, Suchkov maintained his Doctor Degree at the National Institute of Immunology, Russia.
From 1989 through 1995, DrSuchkov was being a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004 - a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, DrSuchkov was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK.
Yu-Xiang Yan has completed her PhD from Capital Medical University, China. She is a professor of Department of Epidemiology and Biostatistics, School of Public Health, Capital Medical University, Beijing, China. Her research area includes Epidemiology of Chronic Diseases and Molecular Epidemiology. She has published more than 20 papers in reputed journals.
Jolanta Gutkowska is Professor of Medicine at UdeM and Experimental Medicine at McGill University. She is recognized by her works of cardiac hormones and diabetes. The most known her accomplishments include biology of natriuretic peptides and discovery of cardiac oxytocin and its role in cardiovascular system in normal and pathological conditions like heart failure. She is the director of Laboratory of Cardiovascular Biochemistry in Research Center CHUM, Montreal. She has published more than 470 papers and has been serving as a supervisor of numerous MS and PhD students.
Marek Jankowski is recognized by his work in molecular biology of hormones involved in cardioprotection. The most known his accomplishments include biology of natriuretic peptides, estrogen receptors and molecular biology of oxytocin in cardiovascular system. He is working in Laboratory of Cardiovascular Biochemistry in Research Center CHUM, Montreal. He has published more than 130 papers in reputed journals and has been serving as a supervisor of numerous MS and PhD students.
Prof. Ivet Koleva is a medical doctor, specialist in Neurology and in Physical & Rehabilitation Medicine (PRM); with 30+ years of clinical practice. She has completed a PhD thesis on ‘Physical Prevention, Therapy and Rehabilitation of Diabetic Polyneuropathy’; and a thesis for Doctor-es-Medical Sciences on ‘Neurorehabilitation in patients with socially important neurological diseases’. Associate professor (2006) and Professor (2010) in PRM. Author of scientific papers, monographs and manuals in the fields of Rehabilitation, Pain Management, Grasp and Gait Rehabilitation.